{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:17:27Z","timestamp":1792513047158,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To investigate changes in disease activity after a large subretinal hemorrhage in polypoidal choroidal vasculopathy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Fifty-two polypoidal choroidal vasculopathy eyes with large subretinal hemorrhage (at initial presentation [n = 33, Group 1] or developed during follow-up [n = 19, Group 2]) were enrolled. Thirty polypoidal choroidal vasculopathy eyes without subretinal hemorrhage were enrolled as controls. All subretinal hemorrhages were treated with pneumatic displacement. Other active lesions were treated with intravitreal ranibizumab on an as-needed basis. Injection-free period, 1-year injection numbers, and polyp presence on indocyanine green angiography were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The injection frequency significantly diminished after hemorrhage (1.2 \u00b1 1.8 in Group 1 and 1.1 \u00b1 2.1 in Group 2) compared with control eyes (3.9 \u00b1 3.0) in both groups (both <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001) and the prehemorrhage period (4.7 \u00b1 1.4) in Group 2 (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). The median injection-free period after hemorrhage was 12.0 months in both groups. At least one polypoidal lesion disappeared after hemorrhage in 7 of 10 eyes (70%) with comparable indocyanine green angiography.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The activity of a polypoidal choroidal vasculopathy lesion diminished after a large subretinal hemorrhage, which was associated with rupture of major polyps.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000001817","type":"journal-article","created":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T22:22:43Z","timestamp":1503526963000},"page":"1993-2000","source":"Crossref","is-referenced-by-count":16,"title":["DISEASE ACTIVITY AFTER DEVELOPMENT OF LARGE SUBRETINAL HEMORRHAGE IN POLYPOIDAL CHOROIDAL VASCULOPATHY"],"prefix":"10.1097","volume":"38","author":[{"given":"Jiwon","family":"Baek","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hui","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Kim's Eye Hospital, Konyang University College of Medicine, Seoul, Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mee Yon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Ki","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230817","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1001\/archopht.117.11.1503","article-title":"Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration","volume":"117","author":"Yannuzzi","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R2-20230817","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/bjo.2004.049296","article-title":"The origins of polypoidal choroidal vasculopathy","volume":"89","author":"Yuzawa","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R3-20230817","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.preteyeres.2009.10.001","article-title":"Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease?","volume":"29","author":"Laude","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"R4-20230817","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0002-9394(02)01404-6","article-title":"Polypoidal choroidal vasculopathy: natural history","volume":"133","author":"Uyama","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R5-20230817","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ajo.2016.06.014","article-title":"Incidence rate of massive submacular hemorrhage and its risk factors in polypoidal choroidal vasculopathy","volume":"169","author":"Cho","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"R6-20230817","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00006982-199010010-00002","article-title":"The posterior uveal bleeding syndrome","volume":"10","author":"Kleiner","year":"1990","journal-title":"Retina"},{"key":"R7-20230817","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00006982-199616030-00001","article-title":"Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration","volume":"16","author":"Avery","year":"1996","journal-title":"Retina"},{"key":"R8-20230817","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/0002-9394(82)90301-4","article-title":"Experimental subretinal hemorrhage in rabbits","volume":"94","author":"Glatt","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"R9-20230817","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000027400","article-title":"Natural history of macular subretinal hemorrhage in age-related macular degeneration","volume":"213","author":"Scupola","year":"1999","journal-title":"Ophthalmologica"},{"key":"R10-20230817","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9394(14)75575-8","article-title":"Factors prognostic of visual outcome in patients with subretinal hemorrhage","volume":"109","author":"Bennett","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"R11-20230817","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.ophtha.2004.07.023","article-title":"Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13","volume":"111","author":"Bressler","year":"2004","journal-title":"Ophthalmology"},{"key":"R12-20230817","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/eye.2016.67","article-title":"Early treatment of acute submacular haemorrhage secondary to wet amd using intravitreal tissue plasminogen activator, C3F8, and an anti-VEGF agent","volume":"30","author":"de Silva","year":"2016","journal-title":"Eye (Lond)"},{"key":"R13-20230817","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/IAE.0b013e3181c969e9","article-title":"Results of vitrectomy for breakthrough vitreous hemorrhage associated with age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"30","author":"Jung","year":"2010","journal-title":"Retina"},{"key":"R14-20230817","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/jop.2010.0066","article-title":"Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage","volume":"26","author":"Kung","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"key":"R15-20230817","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10384-012-0191-y","article-title":"Visual prognosis of eyes with submacular hemorrhage associated with exudative age-related macular degeneration","volume":"56","author":"Ueda-Arakawa","year":"2012","journal-title":"Jpn J Ophthalmol"},{"key":"R16-20230817","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3349\/ymj.2007.48.2.225","article-title":"Polypoidal choroidal vasculopathy in korean patients with large submacular hemorrhage","volume":"48","author":"Yoon","year":"2007","journal-title":"Yonsei Med J"},{"key":"R17-20230817","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0002-9394(99)00078-1","article-title":"Surgical treatment of submacular hemorrhage associated with idiopathic polypoidal choroidal vasculopathy","volume":"128","author":"Shiraga","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R18-20230817","first-page":"119","article-title":"Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization","volume":"21","author":"Grossniklaus","year":"2002","journal-title":"Mol Vis"},{"key":"R19-20230817","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.06.002","article-title":"Molecular pathogenesis of retinal and choroidal vascular diseases","volume":"49","author":"Campochiaro","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"R20-20230817","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10384-016-0434-4","article-title":"Combination therapy with intravitreal tissue plasminogen activator and ranibizumab for subfoveal type 2 choroidal neovascularization","volume":"60","author":"Kachi","year":"2016","journal-title":"Jpn J Ophthalmol"},{"key":"R21-20230817","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0006-291X(03)00656-9","article-title":"Inhibition of endothelial cell proliferation by the recombinant kringle domain of tissue-type plasminogen activator","volume":"304","author":"Kim","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R23-20230817","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s10384-011-0045-z","article-title":"Bevacizumab for serous changes originating from a persistent branching vascular network following photodynamic therapy for polypoidal choroidal vasculopathy","volume":"55","author":"Kim","year":"2011","journal-title":"Jpn J Ophthalmol"},{"key":"R24-20230817","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/bjo.2011.204123","article-title":"Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy","volume":"96","author":"Wakabayashi","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"R25-20230817","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/IAE.0b013e31820f4b21","article-title":"Intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation","volume":"31","author":"Saito","year":"2011","journal-title":"Retina"},{"key":"R26-20230817","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1097\/IAE.0000000000001346","article-title":"Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal subfoveal choroidal thickness","volume":"36","author":"Lee","year":"2016","journal-title":"Retina"},{"key":"R28-20230817","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ophtha.2016.01.035","article-title":"Intravitreal tissue plasminogen activator, ranibizumab, and gas injection for submacular hemorrhage in polypoidal choroidal vasculopathy","volume":"123","author":"Kitagawa","year":"2016","journal-title":"Ophthalmology"},{"key":"R29-20230817","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ajo.2014.12.020","article-title":"Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator","volume":"159","author":"Kimura","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"R30-20230817","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2147\/OPTH.S55413","article-title":"Pneumatic displacement with intravitreal bevacizumab for massive submacular hemorrhage due to polypoidal choroidal vasculopathy","volume":"8","author":"Kitahashi","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"R31-20230817","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jcma.2015.11.004","article-title":"Visual prognosis of massive submacular hemorrhage in polypoidal choroidal vasculopathy with or without combination treatment","volume":"79","author":"Lin","year":"2016","journal-title":"J Chin Med Assoc"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006982-201810000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T01:22:34Z","timestamp":1692235354000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201810000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000001817","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}